世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

細胞解離市場の世界市場規模、シェア、動向、競争、機会、予測、2018-2028年タイプ別(組織解離・細胞剥離)、製品タイプ別(酵素解離製品、非酵素解離製品、器具・付属品)、組織別(上皮組織、結合組織、その他)、エンドユーザー別(バイオテクノロジー企業、製薬企業、学術・研究機関、その他)、地域別


Cell Dissociation Market Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028Segmented By Type (Tissue Dissociation & Cell Detachment), By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories), By Tissue (Epithelial Tissue, Connective Tissue and Others), By End User (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others), By Region

世界の細胞解離市場は、2024年から2028年の予測期間において目覚ましいCAGRで成長すると予想されている。この背景には、バイオ医薬品業界における研究の拡大、個別化医療に対する需要の高まり、細胞ベースの研究... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年7月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
114 英語

 

サマリー

世界の細胞解離市場は、2024年から2028年の予測期間において目覚ましいCAGRで成長すると予想されている。この背景には、バイオ医薬品業界における研究の拡大、個別化医療に対する需要の高まり、細胞ベースの研究に対する公共投資や政府投資の増加といった要因がある。
細胞解離は、ワクチン開発や細胞増殖など、いくつかの研究用途において重要なステップである。
さらに、高度な組織解離における開発の高まり、幹細胞研究における開発と研究研究の増加、酵素を使用しない解離製品における酵素を使用する解離製品との容易な差別化などが、市場の成長を支えている要因であり、予測期間においても市場の成長を促進すると予想される。
感染症の有病率の上昇
人口の間で慢性疾患の有病率が高まっていることが、細胞解離市場の需要を促進している。感染症の有病率の増加は、世界中の人々の間で大きな健康上の懸念となっている。例えば、世界保健機関(WHO)によると、2019年には2億9600万人が慢性B型肝炎に感染し、毎年約150万人が新たに感染している。細胞解離は、疾患診断において非常に重要な用途を見出し、それによって予測期間における世界の細胞解離市場の成長に拍車をかけている。例えば、核酸、RNA、DNAの分離につながる細胞解離は、さらにベクターの同定のために分析され、次いで疾患の同定が行われる。無細胞DNAのシーケンスにより、C型肝炎、HIV、B型肝炎、サイトメガロウイルス、ヒトT細胞リンパトロピックウイルスなどの感染症が検出される。
がん研究への資金と投資の増加
腫瘍組織には様々な細胞が存在するため、様々な細胞サブタイプを特徴付けるために、いくつかの細胞ベースの分析技術が必要となる。腫瘍組織のさらなる研究や調査を行うには、タンパク質分解酵素による処理を受けて単一細胞に解離する必要があり、その後ボルテックスやピペッティング技術を使って機械的に分解する。マイクロ流体デバイスのような技術は、消化された組織凝集体を単一細胞に解離するために使用される。マイクロ流体デバイスの使用により、細胞凝集塊から単一細胞への迅速な解離が可能となり、また完全に生存可能な形態の細胞を得ることができる。マイクロ流体デバイスを用いたこの技術は、酵素を含まない条件でも使用できる。これらの方法は、腫瘍の疑いのある組織の単一細胞検出・精製法の保護に役立ち、それによってがん生物学を進歩させ、がん検出における分子診断を強化するための研究範囲を拡大し、予測期間における市場の成長を支えている。
M&Aの増加に伴う資金調達と投資の増加
ライフサイエンスのさまざまな分野で細胞解離の需要が高まっており、研究や治療への応用範囲が広がっている。市場の成長を促進するため、複数の企業がM&Aを開始している。例えば、ロシュ・ダイアグノスティックスは2021年3月、GenMark Diagnostics Inc.との提携を発表した。この買収により、ロシュはジェンマークのePlexプラットフォームを利用できるようになる。ePlexは、たった1つの患者サンプルを使って様々な病気の検査を可能にする最先端の革新技術である。この技術には、細菌やウイルス性疾患、抗生物質耐性の迅速診断など、数多くの用途がある。さらに、インド、中国、ブラジルなどの新興国は、ライフサイエンス分野の研究開発投資の増加により、市場の需要を支えている。例えば、インドの製薬会社Bioconは2020年に投資を増やし、研究開発に5,879万米ドルを費やしている。
最近の動向
2022年、マーストリヒトで開催された国際質量分析会議において、市場大手のサーモフィッシャーサイエンティフィックが、ハイエンドのバイオ医薬品およびプロテオミクスアプリケーション向けに設計されたOrbitrap Ascend TriBrid装置を発表した。
市場細分化
世界の細胞解離市場は、タイプ、製品タイプ、組織、エンドユーザー、地域、競争環境に基づいてセグメント化される。タイプ別では、市場はさらに組織解離と細胞剥離に区分される。製品タイプに基づけば、市場は酵素的解離製品、非酵素的解離製品、器具&アクセサリーに区分される。組織に基づくと、市場はさらに上皮組織、結合組織、その他に細分化される。エンドユーザー別では、バイオテクノロジー企業、製薬企業、学術・研究機関、その他に細分化される。地域によって、市場は北米、欧州、アジア太平洋、南米、MEAに区分される。
市場プレイヤー
BD Biosciences社、Miltenyi Biotec社、Thermo Fisher Scientific社、GE Healthcare社、Sartorius Group社、Lonza社、Danaher Corporation社、Merck KGaA社、STEMCELL Technologies社、QIAGEN社などが、世界の細胞解離市場で事業を展開している主要企業です。
レポートの範囲
本レポートでは、細胞解離の世界市場を、業界動向に加えて以下のカテゴリーに分類しています:
- 細胞解離市場、タイプ別
o 組織解離
o 細胞剥離
- 細胞解離市場:製品タイプ別
o 酵素解離製品
o 非酵素解離製品
o 機器および付属品
- 細胞解離市場:組織別
o 上皮組織
o 結合組織
o その他
- 細胞解離市場:エンドユーザー別
o バイオテクノロジー企業
o 製薬会社
o 学術・研究機関
その他
- 細胞解離市場:地域別
北米
 米国
 カナダ
 メキシコ
o ヨーロッパ
 ドイツ
 フランス
 イギリス
 イタリア
 スペイン
o アジア太平洋
 中国
 日本
 インド
 韓国
 オーストラリア
中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
 クウェート
o 南米
 ブラジル
 アルゼンチン
 コロンビア
競争状況
企業プロフィール:世界の細胞解離市場における主要企業の詳細分析
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供しています。このレポートでは以下のカスタマイズが可能です:
企業情報
- 追加市場企業(最大5社)の詳細分析とプロファイリング

ページTOPに戻る


目次

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell Dissociation Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Tissue Dissociation & Cell Detachment)
5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
5.2.5. By Company (2022)
5.2.6. By Region
5.3. Product Market Map
6. Asia-Pacific Global Cell Dissociation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. Type
6.2.2. Product Type
6.2.3. Tissue
6.2.4. End user
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Global Cell Dissociation Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. Type
6.3.1.2.2. Product Type
6.3.1.2.3. Tissue
6.3.1.2.4. End user
6.3.2. India Global Cell Dissociation Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. Type
6.3.2.2.2. Product Type
6.3.2.2.3. Tissue
6.3.2.2.4. End user
6.3.3. South Korea Global Cell Dissociation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. Type
6.3.3.2.2. Product Type
6.3.3.2.3. Tissue
6.3.3.2.4. End user
6.3.4. Japan Global Cell Dissociation Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. Type
6.3.4.2.2. Product Type
6.3.4.2.3. Tissue
6.3.4.2.4. End user
6.3.5. Australia Global Cell Dissociation Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. Polymer Type
6.3.5.2.2. Application
6.3.5.2.3. Tissue
6.3.5.2.4. Technique
7. Europe Global Cell Dissociation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. Type
7.2.2. Product Type
7.2.3. Tissue
7.2.4. End user By Country
7.3. Europe: Country Analysis
7.3.1. France Global Cell Dissociation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. Type
7.3.1.2.2. Product Type
7.3.1.2.3. Tissue
7.3.1.2.4. End user
7.3.2. Germany Global Cell Dissociation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. Type
7.3.2.2.2. Product Type
7.3.2.2.3. Tissue
7.3.2.2.4. End user
7.3.3. United Kingdom Global Cell Dissociation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. Type
7.3.3.2.2. Product Type
7.3.3.2.3. Tissue
7.3.3.2.4. End user
7.3.4. Italy Global Cell Dissociation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. Type
7.3.4.2.2. Product Type
7.3.4.2.3. Tissue
7.3.4.2.4. End user
7.3.5. Spain Global Cell Dissociation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. Type
7.3.5.2.2. Product Type
7.3.5.2.3. Tissue
7.3.5.2.4. End user
8. North America Global Cell Dissociation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. Type
8.2.2. Product Type
8.2.3. Tissue
8.2.4. End user
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Global Cell Dissociation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. Type
8.3.1.2.2. Product Type
8.3.1.2.3. Tissue
8.3.1.2.4. End user
8.3.2. Mexico Global Cell Dissociation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. Type
8.3.2.2.2. Product Type
8.3.2.2.3. Tissue
8.3.2.2.4. End user
8.3.3. Canada Global Cell Dissociation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. Type
8.3.3.2.2. Product Type
8.3.3.2.3. Tissue
8.3.3.2.4. End user
9. South America Global Cell Dissociation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. Type
9.2.2. Product Type
9.2.3. Tissue
9.2.4. End user
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Global Cell Dissociation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. Type
9.3.1.2.2. Product Type
9.3.1.2.3. Tissue
9.3.1.2.4. End user
9.3.2. Argentina Global Cell Dissociation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. Type
9.3.2.2.2. Product Type
9.3.2.2.3. Tissue
9.3.2.2.4. End user
9.3.3. Colombia Global Cell Dissociation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. Type
9.3.3.2.2. Product Type
9.3.3.2.3. Tissue
9.3.3.2.4. End user
10. Middle East and Africa Global Cell Dissociation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. Type
10.2.2. Product Type
10.2.3. Tissue
10.2.4. End user
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Global Cell Dissociation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. Type
10.3.1.2.2. Product Type
10.3.1.2.3. Tissue
10.3.1.2.4. End user
10.3.2. Saudi Arabia Global Cell Dissociation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. Type
10.3.2.2.2. Product Type
10.3.2.2.3. Tissue
10.3.2.2.4. End user
10.3.3. UAE Global Cell Dissociation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. Type
10.3.3.2.2. Product Type
10.3.3.2.3. Tissue
10.3.3.2.4. End user
10.3.4. Kuwait Global Cell Dissociation Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. Type
10.3.4.2.2. Product Type
10.3.4.2.3. Tissue
10.3.4.2.4. End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (In case of listed companies)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. BD Biosciences
13.6.2. Miltenyi Biotec
13.6.3. Thermo Fisher Scientific
13.6.4. GE Healthcare
13.6.5. Sartorius Group
13.6.6. Lonza
13.6.7. Danaher Corporation
13.6.8. Merck KGaA
13.6.9. STEMCELL Technologies
13.6.10. QIAGEN
14. Strategic Recommendations

 

ページTOPに戻る


 

Summary

Global Cell Dissociation Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing research in biopharmaceutical industries, growing demand for personalized medicine, and rising public and governmental investments in cell-based research.
Cell dissociation is a significant step in several research applications, such as it is used in developing vaccines and in cell expansion.
Moreover, the rising development in advanced tissue dissociation, increased development & research studies in stem cell research, along with easy differentiation in enzyme-free dissociation products over the enzymatic dissociation products, etc., are factors that are supporting the market growth and are expected to propel it in the forecast period.
Rising Prevalence of Infectious Diseases
The growing prevalence of chronic diseases among the population is propelling the market demand for cell dissociation. The growing prevalence of infectious diseases is a major health concern among people around the world. For instance, according to the World Health Organization (WHO), 296 million people were affected with chronic hepatitis B infection in 2019, with around 1.5 million new infections developing each year. Cell dissociation founds a very significant application in disease diagnosis and thereby adds to the global cell dissociation market growth in the forecast period. For instance, cell dissociation leading to isolation of the nucleic acids, RNA and DNA, is further analyzed for identification of the vector and followed by the identification of the disease. Sequencing of cell-free DNA can result in the detection of infectious diseases such as hepatitis C, HIV, hepatitis B, cytomegalovirus, and human T-cell lymphotropic virus.
Increasing funding & investments for cancer research
Tumor tissues hold a distinct cell range, requiring several cell-based analysis techniques to characterize different cell subtypes. To undergo further research or study of the tumor tissue, it needs to be dissociated into single cells by undergoing treatments with proteolytic enzymes, which is followed by mechanical breakdown using vortexing or pipetting techniques. Techniques such as microfluidic devices are used for the dissociation of digested tissue aggregate into single cells. The microfluidic device usage results in the quick dissociation of cell aggregate into single cells and also results in obtaining cells in fully viable forms. This technique using microfluidic devices can also be used in enzyme-free conditions. These methods thus aid in the protection of single cell detection and purification methods for tumor-suspecting tissue and thereby enhancing the research scope for advancing cancer biology and enhancing molecular diagnosis in cancer detection, thereby supporting the market growth in the forecast period.
Increase in Funding & Investments Along with Rising Mergers & Acquisitions
There is a growing demand for cell dissociation in multiple fields of life sciences, having a wide range of research and therapeutic applications. Several companies have started mergers and acquisitions to propel the growth of the market. For instance, in March 2021, Roche Diagnostics, announced its partnership with GenMark Diagnostics Inc. Through the acquisition, Roche will have access to GenMark's ePlex platform, a cutting-edge innovation that enables testing for a variety of diseases using just one patient sample. Numerous uses of this technique include the quick diagnosis of bacterial and viral illnesses as well as antibiotic resistance. Additionally emerging economies such as India, China, Brazil, etc. are adding to support the market demand with increased rise in investment in research & development in life sciences. For instance, Indian pharmaceutical company Biocon increased investment and spent USD 58.79 million on research & development in 2020.
Recent Developments
In 2022, one of the leading market players, Thermo Fisher Scientific, at the international mass spectroscopy conference in Maastricht, launched the Orbitrap Ascend TriBrid instrument designed for high-end biopharma and proteomic applications.
Market Segmentation
Global Cell Dissociation Market is segmented based on the type, product type, tissue, end user, region, and competitive landscape. Based on the type, the market is further segmented into tissue dissociation & cell detachment. Based on the product type, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories. Based on tissue, the market is further fragmented into epithelial tissue, connective tissue, and others. Depending on the end user, the market is segmented into Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes, and others. Based on the region, the Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
BD Biosciences, Miltenyi Biotec, Thermo Fisher Scientific, GE Healthcare, Sartorius Group, Lonza, Danaher Corporation, Merck KGaA, STEMCELL Technologies, and QIAGEN., etc.., are some of the major players operating in the Global Cell Dissociation Market.
Report Scope:
In this report, Global Cell Dissociation Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
• Cell Dissociation Market, By Type:
o Tissue Dissociation
o Cell Detachment
• Cell Dissociation Market, By Product Type:
o Enzymatic Dissociation Products
o Non-Enzymatic Dissociation Products
o Instruments & Accessories
• Cell Dissociation Market, By Tissue:
o Epithelial Tissue
o Connective Tissue
o Others
• Cell Dissociation Market, By End User:
o Biotechnology Companies
o Pharmaceutical Companies
o Academic and Research Institutes
o Others
• Cell Dissociation Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Kuwait
o South America
 Brazil
 Argentina
 Colombia
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Cell Dissociation Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional Market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered.
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cell Dissociation Market Outlook.
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Tissue Dissociation & Cell Detachment)
5.2.2. By Product Type (Enzymatic Dissociation Products, Non-Enzymatic Dissociation Products, and Instruments & Accessories)
5.2.3. By Tissue (Epithelial Tissue, Connective Tissue, and Others)
5.2.4. By End user (Biotechnology Companies, Pharmaceutical Companies, Academic and Research Institutes and others)
5.2.5. By Company (2022)
5.2.6. By Region
5.3. Product Market Map
6. Asia-Pacific Global Cell Dissociation Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. Type
6.2.2. Product Type
6.2.3. Tissue
6.2.4. End user
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Global Cell Dissociation Market Outlook.
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. Type
6.3.1.2.2. Product Type
6.3.1.2.3. Tissue
6.3.1.2.4. End user
6.3.2. India Global Cell Dissociation Market Outlook.
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. Type
6.3.2.2.2. Product Type
6.3.2.2.3. Tissue
6.3.2.2.4. End user
6.3.3. South Korea Global Cell Dissociation Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. Type
6.3.3.2.2. Product Type
6.3.3.2.3. Tissue
6.3.3.2.4. End user
6.3.4. Japan Global Cell Dissociation Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. Type
6.3.4.2.2. Product Type
6.3.4.2.3. Tissue
6.3.4.2.4. End user
6.3.5. Australia Global Cell Dissociation Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. Polymer Type
6.3.5.2.2. Application
6.3.5.2.3. Tissue
6.3.5.2.4. Technique
7. Europe Global Cell Dissociation Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. Type
7.2.2. Product Type
7.2.3. Tissue
7.2.4. End user By Country
7.3. Europe: Country Analysis
7.3.1. France Global Cell Dissociation Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. Type
7.3.1.2.2. Product Type
7.3.1.2.3. Tissue
7.3.1.2.4. End user
7.3.2. Germany Global Cell Dissociation Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. Type
7.3.2.2.2. Product Type
7.3.2.2.3. Tissue
7.3.2.2.4. End user
7.3.3. United Kingdom Global Cell Dissociation Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. Type
7.3.3.2.2. Product Type
7.3.3.2.3. Tissue
7.3.3.2.4. End user
7.3.4. Italy Global Cell Dissociation Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. Type
7.3.4.2.2. Product Type
7.3.4.2.3. Tissue
7.3.4.2.4. End user
7.3.5. Spain Global Cell Dissociation Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. Type
7.3.5.2.2. Product Type
7.3.5.2.3. Tissue
7.3.5.2.4. End user
8. North America Global Cell Dissociation Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. Type
8.2.2. Product Type
8.2.3. Tissue
8.2.4. End user
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Global Cell Dissociation Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. Type
8.3.1.2.2. Product Type
8.3.1.2.3. Tissue
8.3.1.2.4. End user
8.3.2. Mexico Global Cell Dissociation Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. Type
8.3.2.2.2. Product Type
8.3.2.2.3. Tissue
8.3.2.2.4. End user
8.3.3. Canada Global Cell Dissociation Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. Type
8.3.3.2.2. Product Type
8.3.3.2.3. Tissue
8.3.3.2.4. End user
9. South America Global Cell Dissociation Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. Type
9.2.2. Product Type
9.2.3. Tissue
9.2.4. End user
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Global Cell Dissociation Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. Type
9.3.1.2.2. Product Type
9.3.1.2.3. Tissue
9.3.1.2.4. End user
9.3.2. Argentina Global Cell Dissociation Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. Type
9.3.2.2.2. Product Type
9.3.2.2.3. Tissue
9.3.2.2.4. End user
9.3.3. Colombia Global Cell Dissociation Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. Type
9.3.3.2.2. Product Type
9.3.3.2.3. Tissue
9.3.3.2.4. End user
10. Middle East and Africa Global Cell Dissociation Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. Type
10.2.2. Product Type
10.2.3. Tissue
10.2.4. End user
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Global Cell Dissociation Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. Type
10.3.1.2.2. Product Type
10.3.1.2.3. Tissue
10.3.1.2.4. End user
10.3.2. Saudi Arabia Global Cell Dissociation Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. Type
10.3.2.2.2. Product Type
10.3.2.2.3. Tissue
10.3.2.2.4. End user
10.3.3. UAE Global Cell Dissociation Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. Type
10.3.3.2.2. Product Type
10.3.3.2.3. Tissue
10.3.3.2.4. End user
10.3.4. Kuwait Global Cell Dissociation Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. Type
10.3.4.2.2. Product Type
10.3.4.2.3. Tissue
10.3.4.2.4. End user
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (In case of listed companies)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. BD Biosciences
13.6.2. Miltenyi Biotec
13.6.3. Thermo Fisher Scientific
13.6.4. GE Healthcare
13.6.5. Sartorius Group
13.6.6. Lonza
13.6.7. Danaher Corporation
13.6.8. Merck KGaA
13.6.9. STEMCELL Technologies
13.6.10. QIAGEN
14. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社の世界/地域別市場調査分野での最新刊レポート

本レポートと同じKEY WORD(industry)の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る